- Home
- ITRG vs GNTA Comparison
ITRG vs GNTA Comparison
Compare ITRG & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITRG
- GNTA
- Stock Information
- Founded
- ITRG 1997
- GNTA 2014
- Country
- ITRG Canada
- GNTA Italy
- Employees
- ITRG N/A
- GNTA N/A
- Industry
- ITRG Precious Metals
- GNTA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ITRG Basic Materials
- GNTA Health Care
- Exchange
- ITRG Nasdaq
- GNTA Nasdaq
- Market Cap
- ITRG 302.5M
- GNTA 64.3M
- IPO Year
- ITRG N/A
- GNTA 2021
- Fundamental
- Price
- ITRG $2.28
- GNTA $3.76
- Analyst Decision
- ITRG Strong Buy
- GNTA Strong Buy
- Analyst Count
- ITRG 2
- GNTA 1
- Target Price
- ITRG $3.25
- GNTA $25.00
- AVG Volume (30 Days)
- ITRG 1.5M
- GNTA 7.4K
- Earning Date
- ITRG 08-13-2025
- GNTA 01-01-0001
- Dividend Yield
- ITRG N/A
- GNTA N/A
- EPS Growth
- ITRG N/A
- GNTA N/A
- EPS
- ITRG 0.09
- GNTA N/A
- Revenue
- ITRG $148,447,000.00
- GNTA N/A
- Revenue This Year
- ITRG $871.24
- GNTA N/A
- Revenue Next Year
- ITRG N/A
- GNTA N/A
- P/E Ratio
- ITRG $26.83
- GNTA N/A
- Revenue Growth
- ITRG N/A
- GNTA N/A
- 52 Week Low
- ITRG $0.79
- GNTA $2.74
- 52 Week High
- ITRG $2.29
- GNTA $7.28
- Technical
- Relative Strength Index (RSI)
- ITRG 80.91
- GNTA 54.70
- Support Level
- ITRG $2.05
- GNTA $3.33
- Resistance Level
- ITRG $1.76
- GNTA $4.50
- Average True Range (ATR)
- ITRG 0.11
- GNTA 0.32
- MACD
- ITRG 0.05
- GNTA 0.04
- Stochastic Oscillator
- ITRG 99.24
- GNTA 43.12
About ITRG Integra Resources Corp.
Integra Resources Corp is a precious metals exploration and development company in the Great Basin of the Western USA. Integra is currently focused on advancing its two flagship oxide heap leach projects: the past-producing DeLamar Project located in southwestern Idaho and the Nevada North Project, comprised of the Wildcat and Mountain View deposits, located in northwestern Nevada. The company also holds a portfolio of prospective early-stage exploration projects in Idaho, Nevada, and Arizona.
About GNTA Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.